STAAR Surgical Company
STAA
$29.29
-$1.92-6.15%
NASDAQ
| 04/03/2026 | 01/02/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 61.80% | -38.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 61.80% | -38.98% | |||
| Cost of Revenue | 75.41% | -16.59% | |||
| Gross Profit | 57.42% | -43.83% | |||
| SG&A Expenses | -8.70% | 2.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.68% | -2.17% | |||
| Operating Income | 260.28% | -144.51% | |||
| Income Before Tax | 139.79% | -209.91% | |||
| Income Tax Expenses | 228.55% | -123.65% | |||
| Earnings from Continuing Operations | 128.43% | -306.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 128.43% | -306.09% | |||
| EBIT | 260.28% | -144.51% | |||
| EBITDA | 320.10% | -133.58% | |||
| EPS Basic | 128.34% | -305.59% | |||
| Normalized Basic EPS | 301.00% | -135.27% | |||
| EPS Diluted | 127.17% | -305.59% | |||
| Normalized Diluted EPS | 297.09% | -135.93% | |||
| Average Basic Shares Outstanding | 0.30% | 0.25% | |||
| Average Diluted Shares Outstanding | 2.30% | -1.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||